Covaxin has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days, VK Paul, Member (Health), Niti Aayog said., Covaxin has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days, VK Paul, Member (Health), Niti Aayog said., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way